文献速递艾滋病与性传播感染结核与非结核分枝杆菌

HIV合并肺结核成人抗逆转录病毒治疗中的肺损伤

Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2020-01-01

南非前瞻性队列纳入HIV合并肺结核成人,于ART启动前及启动后4周行FDG PET-CT评估肺部炎症,并纵向随访肺功能至48周。ART前肺部炎症越重肺功能与呼吸道症状越差,近半数受试者第4周肺部炎症及肺功能恶化,且与病原特异性CD4 T细胞恢复增强相关,早期肺功能下降独立关联TB治疗完成后数月肺功能持续低下。

要点

  • ART前肺部FDG摄取越高,肺功能与呼吸道症状越差。
  • 近半数患者ART第4周出现肺部炎症和肺功能恶化。
  • 早期肺功能下降预示TB治疗后肺功能持续受损。

核心结论

  • ART可致HIV合并肺结核成人肺部炎症增加和肺功能下降,与CD4 T细胞恢复增强相关,并关联TB治疗后肺功能持续受损。

研究设计与样本

  • 南非前瞻性队列研究,随访HIV合并肺结核成人ART启动前至启动后48周,基线及ART后4周行FDG PET-CT、肺功能、呼吸症状问卷和流式细胞术。

主要发现

  • ART前肺部总糖酵解活性越高,肺功能和呼吸道症状越差。
  • 近半数受试者ART第4周肺部炎症和肺功能恶化。
  • 第4周肺部炎症和肺功能恶化均与病原特异性功能性CD4 T细胞反应增幅更大相关。
  • 早期肺功能下降独立关联TB治疗完成后数月肺功能持续较低。

临床怎么用

  • HIV合并肺结核患者启动ART后应关注肺部炎症与肺功能变化,尤其CD4恢复明显者,并随访至TB治疗后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune restoration on antiretroviral therapy (ART) can drive inflammation in people living with human immunodeficiency virus (HIV) who have pulmonary tuberculosis (TB), but its effects on the lungs have not been assessed. We evaluated associations between pulmonary inflammation, recovery of pathogen-specific CD4 T-cell function, and lung injury prior to and after ART initiation in adults with HIV and pulmonary TB. METHODS: This was a prospective cohort study in South Africa, following adults with HIV and pulmonary TB prior to and up to 48 weeks after ART initiation. Pulmonary-specific inflammation was defined as total glycolytic activity (TGA) on [18]F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) at baseline and 4 weeks after ART initiation. Spirometry, respiratory symptom tests, and flow cytometry were performed at the same times to assess lung involvement and the frequency of mycobacteria-specific CD4 T-cells. In addition, we evaluated lung function longitudinally up to 48 weeks after ART initiation. RESULTS: Greater lung TGA on FDG PET-CT was associated with worse lung function and respiratory symptoms prior to ART initiation, and nearly half of subjects experienced worsening lung inflammation and lung function at Week 4 of ART. Worsening Week 4 lung inflammation and pulmonary function were both associated with greater increases in pathogen-specific functional CD4 T-cell responses on ART, and early decreases in lung function were independently associated with persistently lower lung function months after TB treatment completion. CONCLUSIONS: Increases in pulmonary inflammation and decreases in lung function are common on ART, relate to greater ART-mediated CD4 T-cell restoration, and are associated with the persistent impairment of lung function in individuals with HIV/TB.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ravimohan S, Auld SC, Maenetje P, et al. Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis. Clin Infect Dis. 2020. PMID: 31242296. doi:10.1093/cid/ciz560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。